A simulation modeling study examining the downstream effects of follow-up schedules for screen-detected nodules
- Determine whether the Lung-RADS guidelines are optimal for follow-up and treatment of lung nodules
- Investigate modifications to Lung-RADS with the aim of improving effectiveness
- Examine the cost-effectiveness of Lung-RADS and other such sets of guidelines
- Formulate recommendations for lung nodule management
Mark Hammer, M.D. (Brigham and Women's Hospital)
Eduardo Barbosa Jr., M.D. (U. Penn Perelman School of Medicine)
-
Cost-Effectiveness of Follow-Up for Subsolid Pulmonary Nodules in High-Risk Patients.
Hammer MM, Palazzo LL, Paquette A, Eckel AL, Jacobson FL, Barbosa EM, Kong CY
J Thorac Oncol. 2020 Mar 11 PUBMED -
Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
Hammer MM, Palazzo LL, Kong CY, Hunsaker AR
Radiology. 2019 Nov; Volume 293 (Issue 2): Pages 441-448 PUBMED